Roth Capital Issues Negative Forecast for Allstate Earnings

The Allstate Co. (NYSE:ALL) – Analysts at Roth Capital decreased their Q2 2025 earnings estimates for Allstate in a report issued on Thursday, May 1st. Roth Capital analyst H. Fong now forecasts that the insurance provider will post earnings per share of $3.11 for the quarter, down from their prior estimate of $3.59. The consensus estimate for Allstate’s current full-year earnings is $18.74 per share. Roth Capital also issued estimates for Allstate’s Q3 2025 earnings at $4.68 EPS and Q4 2025 earnings at $6.68 EPS.

Allstate (NYSE:ALL) last issued its quarterly earnings results on Wednesday, April 30th. The insurance provider reported $3.53 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.98 by ($0.45). Allstate had a return on equity of 28.20% and a net margin of 7.28%. The company had revenue of $14.30 billion for the quarter, compared to analysts’ expectations of $16.41 billion. During the same quarter in the previous year, the business earned $5.13 EPS. The company’s revenue for the quarter was up 7.8% on a year-over-year basis.

ALL has been the topic of a number of other reports. Raymond James restated a “strong-buy” rating and issued a $250.00 price objective (up from $240.00) on shares of Allstate in a research note on Monday. Argus raised shares of Allstate from a “hold” rating to a “buy” rating in a research report on Monday, March 3rd. StockNews.com upgraded shares of Allstate from a “hold” rating to a “buy” rating in a research note on Thursday, May 1st. Evercore ISI increased their target price on Allstate from $227.00 to $230.00 and gave the stock an “outperform” rating in a research report on Thursday, May 1st. Finally, JPMorgan Chase & Co. lifted their price target on Allstate from $217.00 to $222.00 and gave the company an “overweight” rating in a research report on Tuesday, April 8th. One analyst has rated the stock with a sell rating, one has issued a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, Allstate presently has an average rating of “Moderate Buy” and an average target price of $223.60.

Allstate Stock Performance

Shares of ALL opened at $200.38 on Monday. Allstate has a 1 year low of $156.66 and a 1 year high of $212.91. The company has a debt-to-equity ratio of 0.42, a current ratio of 0.36 and a quick ratio of 0.40. The stock’s fifty day moving average price is $198.73 and its two-hundred day moving average price is $194.90. The firm has a market cap of $53.13 billion, a PE ratio of 11.79, a PEG ratio of 1.01 and a beta of 0.32.

Allstate announced that its board has authorized a share repurchase plan on Wednesday, February 26th that authorizes the company to repurchase $1.50 billion in shares. This repurchase authorization authorizes the insurance provider to buy up to 3% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company’s management believes its stock is undervalued.

Allstate Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, April 1st. Shareholders of record on Monday, March 10th were paid a $1.00 dividend. This represents a $4.00 dividend on an annualized basis and a yield of 2.00%. The ex-dividend date was Monday, March 10th. This is a boost from Allstate’s previous quarterly dividend of $0.92. Allstate’s payout ratio is currently 27.32%.

Insider Transactions at Allstate

In related news, CFO Jesse E. Merten sold 40,102 shares of the company’s stock in a transaction on Monday, February 10th. The shares were sold at an average price of $186.53, for a total value of $7,480,226.06. Following the completion of the transaction, the chief financial officer now directly owns 18,115 shares in the company, valued at approximately $3,378,990.95. The trade was a 68.88 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 1.80% of the company’s stock.

Institutional Trading of Allstate

A number of hedge funds have recently bought and sold shares of ALL. Rehmann Capital Advisory Group lifted its holdings in shares of Allstate by 3.2% in the 1st quarter. Rehmann Capital Advisory Group now owns 1,630 shares of the insurance provider’s stock worth $338,000 after acquiring an additional 51 shares during the last quarter. Vantage Point Financial LLC lifted its stake in Allstate by 3.6% in the first quarter. Vantage Point Financial LLC now owns 1,495 shares of the insurance provider’s stock worth $310,000 after purchasing an additional 52 shares during the last quarter. Confluence Wealth Services Inc. boosted its position in Allstate by 0.7% during the first quarter. Confluence Wealth Services Inc. now owns 8,000 shares of the insurance provider’s stock valued at $1,558,000 after buying an additional 54 shares during the period. Achmea Investment Management B.V. boosted its position in Allstate by 0.3% during the first quarter. Achmea Investment Management B.V. now owns 20,586 shares of the insurance provider’s stock valued at $4,262,000 after buying an additional 57 shares during the period. Finally, Avidian Wealth Enterprises LLC increased its holdings in shares of Allstate by 1.7% in the first quarter. Avidian Wealth Enterprises LLC now owns 3,552 shares of the insurance provider’s stock worth $735,000 after buying an additional 59 shares during the period. Institutional investors own 76.47% of the company’s stock.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.